Literature DB >> 7556187

Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region.

P Antonson1, M G Pray, A Jacobsson, K G Xanthopoulos.   

Abstract

The product of the c-myc proto-oncogene, Myc, has been implicated in the transcriptional regulation of several genes, acting either as an activator or repressor of gene expression. To determine whether Myc is involved in the modulation of the expression of the CCAAT/enhancer-binding protein alpha (C/EBP alpha) gene, we used both stable cell lines overexpressing Myc and transient co-transfection assays. We show that the endogenous C/EBP alpha protein level is repressed in stable cell lines overexpressing Myc. We also show that enforced expression of Myc in mouse hibernoma HIB-1B cells dramatically repressed the expression of C/EBP alpha--promoter-reporter fusion genes. This effect of Myc was mediated through the core promoter region. Mutation of the initiator site could not abolish this affect, indicating that Myc may interact with some component(s) of the basal transcription machinery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556187     DOI: 10.1111/j.1432-1033.1995.397zz.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing.

Authors:  R Yamanaka; G D Kim; H S Radomska; J Lekstrom-Himes; L T Smith; P Antonson; D G Tenen; K G Xanthopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 2.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

3.  Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression.

Authors:  S K Oster; W W Marhin; C Asker; L M Facchini; P A Dion; K Funa; M Post; J M Sedivy; L Z Penn
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis.

Authors:  S D Conzen; K Gottlob; E S Kandel; P Khanduri; A J Wagner; M O'Leary; N Hay
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  c-Myc is a critical target for c/EBPalpha in granulopoiesis.

Authors:  L M Johansen; A Iwama; T A Lodie; K Sasaki; D W Felsher; T R Golub; D G Tenen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.

Authors:  Junling Si; Xueyan Yu; Yingjie Zhang; James W DeWille
Journal:  Mol Cancer       Date:  2010-04-28       Impact factor: 27.401

7.  Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors.

Authors:  Makoto Nakamura; Lizi Wu; James D Griffin; Satoru Kojika; Kumiko Goi; Takeshi Inukai; Kanji Sugita
Journal:  Leuk Res       Date:  2018-07-30       Impact factor: 3.156

8.  Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region.

Authors:  Pelagia Foka; Scott A Irvine; Feray Kockar; Dipak P Ramji
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

9.  IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells.

Authors:  Karim Shamsasenjan; Ken-Ichiro Otsuyama; Saeid Abroun; Mohd S Iqbal; Maged S Mahmoud; Hideki Asaoku; Michio M Kawano
Journal:  Int J Hematol       Date:  2009-03-04       Impact factor: 2.490

10.  Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder.

Authors:  Eva Chung; Chia-Lin Hsu; Motonari Kondo
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.